메뉴 건너뛰기




Volumn 16, Issue 8, 2012, Pages 1338-1347

Development of a second-generation process to antibacterial candidate sulopenem

Author keywords

[No Author keywords available]

Indexed keywords

ACTIVE PHARMACEUTICAL INGREDIENTS; CONTRACTION SEQUENCES; DEALLYLATION; LOW LEVEL; MEDICINAL CHEMISTRY; PHASE 1; SCALE-UP; SECOND-GENERATION SYNTHESIS; TARGET MOLECULE; TRITHIOCARBONATE;

EID: 84865256250     PISSN: 10836160     EISSN: 1520586X     Source Type: Journal    
DOI: 10.1021/op300130p     Document Type: Article
Times cited : (11)

References (67)
  • 23
    • 48249148548 scopus 로고    scopus 로고
    • EMEA/CHMP/SWP/4446/2000; Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMEA): London
    • For further guidance see: Guideline on the Specification Limits for Residues of Metal Catalysts or Metal Reagents, EMEA/CHMP/SWP/4446/2000; Committee for Medicinal Products for Human Use (CHMP), European Medicines Agency (EMEA): London, 2008; http://www.ema.europa.eu/docs/en-GB/document-library/ Scientific-guideline/2009/09/WC500003586.pdf.
    • (2008) Guideline on the Specification Limits for Residues of Metal Catalysts or Metal Reagents


* 이 정보는 Elsevier사의 SCOPUS DB에서 KISTI가 분석하여 추출한 것입니다.